A Study to Assess LBL-007 in Combination With Toripalimab and Axitinib Tablets Subjects With Advanced Melanoma
Clinical trial NCT04640545 · COMPLETED
Trial details
- NCT number
- NCT04640545
- Sponsor
- Nanjing Leads Biolabs Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2024-08-19
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.